Dr Lal PathLabs
- Company typePublic
- Founded1949
- HeadquartersHaryana, India
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
Dr Lal PathLabs firmographics
Firmographics- Name
- Dr Lal PathLabs
- Legal name
- Dr Lal PathLabs Limited
- Website
- https://lalpathlabs.com
- Company type
- Public
- Founded year
- 1949
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Dr Lal PathLabs industry classification
Industry- Product category
- Diagnostic Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industries
- Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Clinical Research & Trial Central Laboratories (HLAFAMAL)
Keywords
Where Dr Lal PathLabs is headquartered
LocationHeadquarters
- HQ city
- Haryana
- HQ country
- India
- HQ region
- Asia
Offices5 records
Markets served
Dr Lal PathLabs business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D, Marketing or Sales
Revenue model
- Pathology and Diagnostic Testing Services: Core revenue from pathology tests including blood tests, pathology panels, and health check-up packages offered to individual consumers and corporate clients through network of labs and collection centres.
- Radiology and Imaging Services: Revenue from radiology services including MRI, CT scan, X-ray, ultrasound, ECG, echocardiography, and mammography offered at diagnostic centres.
- SwasthFit GLP-1 Subscription Program: Subscription-based monitoring program for Type 2 Diabetes and Obesity combining diagnostic testing with diet and exercise coaching. Four tiers ranging from 1-week to 12-month subscriptions.
- Corporate Healthcare Services: Employee health check-up programs, drug tests, food handler check-ups, and pre-employment examinations for corporate clients across India.
- Sovaaka Premium Wellness Services: Premium diagnostic experience centre offering personalized wellness programs, genetic testing, AI-supported imaging, and lifestyle-based healthcare with packages priced between Rs 11,000 and Rs 35,000.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | SwasthFit Super 1 - Basic wellness package with 34 parameters |
| Unit Pricing | Pay-as-you-go | SwasthFit Super 2 - Intermediate wellness package with 57 parameters |
| Unit Pricing | Pay-as-you-go | SwasthFit Super 3 - Advanced wellness package with 36 parameters |
| Unit Pricing | Pay-as-you-go | SwasthFit Super 4 - Premium wellness package with 59 parameters |
| Unit Pricing | Pay-as-you-go | SwasthFit Complete Health Check - Comprehensive package with 106 parameters |
| Subscription | Monthly | SwasthFit GLP Screen - 1 week subscription |
| Subscription | Monthly | SwasthFit GLP Monitor - 3 months subscription |
| Subscription | Multi-year contract | SwasthFit GLP Sustain - 6 months subscription |
| Subscription | Multi-year contract | SwasthFit GLP Total - 12 months subscription |
| Unit Pricing | Pay-as-you-go | Allergy Comprehensive Profile |
| Unit Pricing | Pay-as-you-go | Radiology Services - ECG/EKG |
| Unit Pricing | Pay-as-you-go | Radiology Services - Echocardiography |
Go-to-market motion4 records
Distribution channels8 records
Marketing channels8 records
Dr Lal PathLabs product offering
Product offeringCore offering
Dr Lal PathLabs operates a pan-India diagnostic services network offering pathology and radiology testing through 290+ laboratories, 6,600+ patient service centres, and 12,300+ pick-up points. The company provides over 5,000 tests and panels including routine blood tests, molecular diagnostics, genetic testing, imaging services (MRI, CT, X-ray, ultrasound, ECG, echocardiography), and bundled preventive health check-up packages such as SwasthFit and the premium Sovaaka vertical. Revenue is generated primarily through per-test and package fees for individual consumers, corporate health programs, and home sample collection services.
Product overview
Dr Lal PathLabs operates as a comprehensive diagnostic services platform offering pathology and radiology testing across India. The core product portfolio includes SwasthFit bundled health checkup packages (Super 1-4, Complete Health Check), the AI-powered SwasthFit GLP-1 Program for diabetes and obesity management, and the premium wellness brand Sovaaka launched in January 2026. Supporting services include radiology imaging (MRI, CT, X-Ray, Ultrasound, Mammography, ECG, Echo), home collection, corporate tie-ups, and specialty testing programs including pregnancy packages, allergy testing, and the PrecisionCHD AI-enabled coronary heart disease test. The company processes samples through a network of 290+ clinical laboratories and over 6,600 patient service centres across India, with international operations in 14+ countries.
Differentiator
Problem solved
Functional benefit
Brands
- Sovaaka: Premium wellness vertical / Diagnostic Experience Centre offering personalized wellness programs combining advanced diagnostics, genetic testing, AI-supported imaging, and lifestyle-based healthcare. Programs include Eterna for women and Vita for men.
- SwasthFit
Products and services
- Pathology Tests Core diagnostic testing service offering over 5,000 tests and panels including blood tests, metabolic panels, infectious disease testing, cancer screening, genetic testing, molecular diagnostics, and specialized pathology services across all major disease categories. For individual consumers, hospitals, and referring doctors.
- Radiology Services Comprehensive medical imaging services including MRI, CT Scan, X-Ray, Ultrasound, Mammography, ECG, Echo/2D Echo, TMT (Treadmill Test), Stress Echo, Holter monitoring, Pulmonary Function Test, Uroflowmetry, and OPG dental imaging. Available across the Delhi/NCR network for individual consumers and referring physicians.
- SwasthFit Health Check Packages Bundled health check-up packages including SwasthFit Super 1-4 (34-59 parameters) and SwasthFit Complete Health Check (106 parameters) covering diabetes, thyroid, heart health, and general wellness, with 40-49% discounts from list prices. Targeted at individual consumers for preventive screening.
- SwasthFit GLP-1 Program Subscription-based monitoring program for Type 2 Diabetes and Obesity management combining structured diagnostic testing (85+ parameters) with AI-enabled food scanning, face scan technology, dietician consultations, and exercise coaching. Four subscription tiers (1 week to 12 months) priced from Rs 6,500 to Rs 21,500. For individual consumers managing metabolic conditions.
- Sovaaka Premium Wellness Premium Diagnostic Experience Centre offering personalized wellness programs combining advanced diagnostics, genetic testing, AI-supported imaging, and lifestyle-based healthcare. Doctor-designed programs include Eterna for women and Vita for men, with services like low-dose CT, 1.5T MRI, and DEXA scanning. Packages priced between Rs 11,000 and Rs 35,000. For affluent, wellness-focused consumers.
- Pregnancy Packages Specialized trimester-based pregnancy testing packages covering first, second, and third trimester including Pregnancy Package-6 (55 parameters) and Pregnancy Package-7 (42 parameters), for expectant mothers and obstetricians.
- Allergy Testing Comprehensive allergy testing including Allergy Comprehensive Profile (Rs 13,790 covering 100+ allergens), Food Intolerance Test (214 parameters), Immunoglobulin IgE, and specialized panels for dust, mold, milk, and food allergens. Over 100 allergy test types available. For individual consumers and referring physicians.
- Oncopro Cancer Diagnostics Oncology-focused diagnostic program offering cancer screening, tumor marker panels, and specialized oncology testing under the Oncopro brand, for individual consumers and referring oncologists.
- Diabetic Care Program Structured diabetes care program combining diagnostic testing, monitoring, and lifestyle guidance for individuals managing Type 1 and Type 2 diabetes.
- Home Collection Service Home sample collection service allowing patients to book home visits for pathology sample collection. Includes prescription upload and callback request for test booking assistance, supporting convenience for individual consumers and elderly or mobility-limited patients.
- Corporate Health Programs Corporate health screening solutions including annual checkups, pre-employment checkups, drug tests, food handler checkups, and COVID-related testing, with customized packages for corporate employees and families, available on-site and off-site. For HR teams, EHS functions, and corporate administration.
- PrecisionCHD Test Clinical blood test using epigenetics, genetics, and AI to detect coronary heart disease at the molecular level, including non-obstructive forms that standard angiograms typically cannot identify. Launched in January 2026 in partnership with Cardio Diagnostics and Aimil Ltd. for individual consumers and cardiologists.
Quantifiable outcome
- 85.6M+ samples collected with 50+ quality checks per sample
- +3 more outcomes
Companies that use Dr Lal PathLabs
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Dr Lal PathLabs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability7 records
Feature5 records
Dr Lal PathLabs partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered strategic, core and minor.
- Cardio Diagnostics Holdings, Inc.strategicStrategic partnership to launch the PrecisionCHD test in India for detecting and managing coronary heart disease. This is Cardio Diagnostics' first expansion outside the United States. The test uses epigenetics, genetics, and AI technology to detect CHD at the molecular level, including non-obstructive forms that standard angiograms cannot identify. Initial phase integration into Dr. Lal PathLabs' network of over 290 clinical laboratories with commercial rollout expected in 2026.
- Aimil Ltd.strategicTripartite partnership with Cardio Diagnostics and Aimil Ltd. to launch PrecisionCHD test in India. Aimil serves as a distribution and implementation partner for the technology in the Indian market.
- Siemens HealthineerscoreDigital transformation partnership implementing the Atellica Solution, Aptio Automation, and integrated IT tools at Dr. Lal PathLabs' national reference lab in Delhi. The implementation enabled reduction of total automation turnaround time by over 50%, reduced sample splitting by 93%, and improved Six Sigma assay performance. Partnership enables scalable, standardized workflows across the vast lab network.
- ABDM (Ayushman Bharat Digital Mission)coreIntegration with India's national digital health ecosystem, enabling patients to create ABHA (Ayushman Bharat Health Account) numbers and link their medical records. The platform supports 333M+ ABHA addresses created and 235M+ health records linked, enhancing digital health accessibility.
- International Partner NetworkminorPartnership network in 14+ countries operating 90+ partners including hospitals and laboratories. Enables diagnostic services for patients and healthcare providers across international markets with 420+ tests per day conducted internationally.
Scale indicators14 records
Recent moves8 records
Expansion highlights6 records
Dr Lal PathLabs competitors and assessment
Company assessmentDirect peers
- Metropolis Healthcare: Metropolis Healthcare is one of India's leading diagnostic chains with a comparable B2C and B2B pathology/radiology model. It directly competes with Dr Lal PathLabs on routine and specialty tests across metros and tier-2 cities, with a similar test menu, home collection, and franchise footprint.
- SRL Diagnostics (Agilus Diagnostics): SRL Diagnostics (rebranded as Agilus) is a pan-India diagnostic chain offering pathology and radiology with a network of labs and collection centres. It is a direct competitor to Dr Lal PathLabs across routine and specialty testing, hospital reference work, and preventive health packages.
- Thyrocare Technologies: Thyrocare is a preventive and wellness-focused diagnostic lab known for low-cost, high-volume test packages. Now owned by PharmEasy, it competes directly on bundled pricing for routine and preventive tests, particularly targeting price-sensitive Indian consumers.
- Apollo Diagnostics: Apollo Diagnostics is the diagnostics arm of Apollo Hospitals, offering pathology and imaging services across India. It competes with Dr Lal PathLabs across hospital-tied and standalone patient service centres, leveraging the Apollo brand and integrated care ecosystem.
- Neuberg Diagnostics: Neuberg Diagnostics operates a network of pathology labs across India with strength in molecular diagnostics and integrated testing. It is comparable to Dr Lal PathLabs on test menu breadth, NABL/CAP-accredited reference labs, and South/West India footprint.
Regional players
- Vijaya Diagnostic Centre: Vijaya Diagnostic Centre is a leading diagnostic chain headquartered in Hyderabad with strong presence in South India. It offers comparable pathology and radiology services to Dr Lal PathLabs but with a primarily regional (South India) concentration.
Emerging players
- Orange Health Labs: Orange Health Labs is a tech-enabled, at-home diagnostic startup processing ~300,000 samples monthly. It targets the same urban, digital-first consumer segment as Dr Lal PathLabs with rapid home collection and digital reporting, pressuring on speed and convenience.
- Healthians: Healthians is an at-home diagnostic and wellness startup offering preventive health packages and online booking. It overlaps with Dr Lal PathLabs on the SwasthFit-style bundled health check-up category and the digital home-collection consumer.
Broad incumbents
- Tata 1mg (Tata Digital): Tata 1mg is a broad digital health platform offering diagnostics, e-pharmacy, and teleconsultation under the Tata group. It competes with Dr Lal PathLabs on online test booking, home collection, and bundling, leveraging the Tata brand and a much larger consumer-facing ecosystem.
- Quest Diagnostics: Quest Diagnostics is one of the world's largest clinical laboratory networks, offering routine and advanced diagnostics globally. It is comparable to Dr Lal PathLabs on test menu, reference lab operations, and CAP-accredited quality standards, and serves as a global scale benchmark.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Dr Lal PathLabs social profiles
Digital presenceDr Lal PathLabs compliance and trust
Trust signalCompliance5 records
Dr Lal PathLabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Dr Lal PathLabs leadership team
Management profileNumber of profiles
Profiles14 records
Dr Lal PathLabs subsidiaries and ownership
Company hierarchySubsidiaries3 records
Dr Lal PathLabs funding detail
Funding detailFunding overview
Funding rounds2 records
Investors10 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Dr Lal PathLabs M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Dr Lal PathLabs
What does Dr Lal PathLabs do?
Dr Lal PathLabs operates a pan-India diagnostic services network offering pathology and radiology testing through 290+ laboratories, 6,600+ patient service centres, and 12,300+ pick-up points. The company provides over 5,000 tests and panels including routine blood tests, molecular diagnostics, genetic testing, imaging services (MRI, CT, X-ray, ultrasound, ECG, echocardiography), and bundled preventive health check-up packages such as SwasthFit and the premium Sovaaka vertical. Revenue is generated primarily through per-test and package fees for individual consumers, corporate health programs, and home sample collection services.
Is Dr Lal PathLabs a public or private company?
Dr Lal PathLabs is a public company. It is classified as public and is currently operating.
When was Dr Lal PathLabs founded?
Dr Lal PathLabs was founded in 1949. It employs 1,001 to 5,000 people.
Where is Dr Lal PathLabs based?
Dr Lal PathLabs is headquartered in Haryana, India, in the Asia region.
How does Dr Lal PathLabs make money?
Five revenue lines are on record. Pathology and Diagnostic Testing Services are the primary driver. The others are radiology and Imaging Services, swasthFit GLP-1 Subscription Program, corporate Healthcare Services and sovaaka Premium Wellness Services.
Who are Dr Lal PathLabs's main competitors?
Direct peers on record are Metropolis Healthcare, SRL Diagnostics (Agilus Diagnostics), Thyrocare Technologies, Apollo Diagnostics and Neuberg Diagnostics. Vijaya Diagnostic Centre is listed as a regional player. Emerging players are Orange Health Labs and Healthians. Broad incumbents are Tata 1mg (Tata Digital) and Quest Diagnostics.
Does Dr Lal PathLabs have an API?
No public API is recorded for Dr Lal PathLabs.
What industry is Dr Lal PathLabs in?
Dr Lal PathLabs's product category is Diagnostic Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAGAEAB, Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry). Its NAICS code is 621511 and its SIC code is 8071.